- Brazil
- /
- Healthcare Services
- /
- BOVESPA:QUAL3
Should You Investigate Qualicorp Consultoria e Corretora de Seguros S.A. (BVMF:QUAL3) At R$1.78?
While Qualicorp Consultoria e Corretora de Seguros S.A. (BVMF:QUAL3) might not have the largest market cap around , it led the BOVESPA gainers with a relatively large price hike in the past couple of weeks. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine Qualicorp Consultoria e Corretora de Seguros’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.
See our latest analysis for Qualicorp Consultoria e Corretora de Seguros
Is Qualicorp Consultoria e Corretora de Seguros Still Cheap?
Qualicorp Consultoria e Corretora de Seguros is currently expensive based on our price multiple model, where we look at the company's price-to-earnings ratio in comparison to the industry average. We’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 76.06x is currently well-above the industry average of 13.8x, meaning that it is trading at a more expensive price relative to its peers. Furthermore, Qualicorp Consultoria e Corretora de Seguros’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach levels around its industry peers, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.
What does the future of Qualicorp Consultoria e Corretora de Seguros look like?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Qualicorp Consultoria e Corretora de Seguros' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? QUAL3’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe QUAL3 should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you’ve been keeping tabs on QUAL3 for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for QUAL3, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.
If you want to dive deeper into Qualicorp Consultoria e Corretora de Seguros, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 4 warning signs for Qualicorp Consultoria e Corretora de Seguros (of which 2 are concerning!) you should know about.
If you are no longer interested in Qualicorp Consultoria e Corretora de Seguros, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Valuation is complex, but we're here to simplify it.
Discover if Qualicorp Consultoria e Corretora de Seguros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:QUAL3
Qualicorp Consultoria e Corretora de Seguros
Qualicorp Consultoria e Corretora de Seguros S.A.
Undervalued with moderate growth potential.
Market Insights
Weekly Picks

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

EU#4 - Turning Heritage into the World’s Strongest Luxury Empire

The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Recently Updated Narratives

Project Ixian Accelerated Rollout will Drive Valuation Expansion to £0.0150.

EU#5 - From Industrial Giant to the Digital Operating System of the Real World

Norwegian Air Shuttle's revenue will grow by 73.56% and profitability will soar
Popular Narratives
Undervalued Key Player in Magnets/Rare Earth

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

The Strategic Revaluation of Adobe: A Critical Analysis of Market Sentiment
Trending Discussion
As a gamer, I would not touch this company now. They are hated by the community and have been releasing major flops on their AAA games during the last 5 years (for good reasons). It is true that the valuation is ridiculously low compared to what the licenses are worth, but if the trend continues the value of those will also decline. Management needs to almost make a 180° turnaround to get things right. I agree that a take-private deal before it is too late might be the best option for an investor entering today. We might also see a split sales of the different studios. It is a very risky play, but potentially with high reward.
